Cogent Biosciences Inc Q1 2026 Earnings Wider Loss but Stock Edges Higher SEER Q1 2026 Earnings Slight EPS Beat Amidst Quiet Revenue Disclosure NGNE Q1 2026 Earnings EPS Misses Estimates as Biotech Continues RD Focus ADXN Q1 2024 Earnings ClinicalStage Biotech Reports Net Loss as Pipeline Advances CYH Q1 2026 Earnings Significant EPS Miss Amid Operational Challenges FBNC Q1 2026 Earnings Slight EPS Beat Amid Stable Performance